AR108992A1 - Formulaciones líquidas estabilizadas que contienen picosulfato - Google Patents

Formulaciones líquidas estabilizadas que contienen picosulfato

Info

Publication number
AR108992A1
AR108992A1 ARP170101886A ARP170101886A AR108992A1 AR 108992 A1 AR108992 A1 AR 108992A1 AR P170101886 A ARP170101886 A AR P170101886A AR P170101886 A ARP170101886 A AR P170101886A AR 108992 A1 AR108992 A1 AR 108992A1
Authority
AR
Argentina
Prior art keywords
picosulfate
sodium
formulations containing
liquid formulations
liquid formulation
Prior art date
Application number
ARP170101886A
Other languages
English (en)
Inventor
Nipul Ghanshyambhai Patel
Alfred Chi-Yeh Liang
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of AR108992A1 publication Critical patent/AR108992A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicación 1: Una formulación líquida que comprende: picosulfato; citrato de magnesio y un antioxidante. Reivindicación 2: La formulación líquida de la reivindicación 1, en donde el picosulfato es picosulfato de sodio. Reivindicación 5: La formulación líquida de cualquiera de las reivindicaciones 1 a 4, en donde el antioxidante se selecciona entre ácido ascórbico o una sal o un éster del mismo, hidroxianisol butilado, hidroxitolueno butilado, histidina, D-manosa, ácido propiónico, metabisulfito de potasio, galato de propilo, metabisulfito de sodio, sulfito de sodio, tiosulfato de sodio, dióxido de azufre y a-tocoferol.
ARP170101886A 2016-07-08 2017-07-07 Formulaciones líquidas estabilizadas que contienen picosulfato AR108992A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662360188P 2016-07-08 2016-07-08

Publications (1)

Publication Number Publication Date
AR108992A1 true AR108992A1 (es) 2018-10-17

Family

ID=59523223

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170101886A AR108992A1 (es) 2016-07-08 2017-07-07 Formulaciones líquidas estabilizadas que contienen picosulfato

Country Status (4)

Country Link
US (2) US20180015078A1 (es)
AR (1) AR108992A1 (es)
TW (1) TW201804996A (es)
WO (1) WO2018009761A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101420315B1 (ko) 2014-03-19 2014-07-17 남봉길 약학적 액제 조성물
CN109310774A (zh) 2015-08-17 2019-02-05 费林股份公司 含有匹可硫酸盐和柠檬酸镁的液体制剂
US20240325436A1 (en) * 2021-06-17 2024-10-03 Braintree Laboratories, Inc. Safe Flavoring Composition to Improve Compliance in Colon Cleansing Compositions
CN116585261B (zh) * 2023-05-17 2024-05-14 深圳市贝美药业有限公司 药物液体组合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010069A (en) * 1989-05-15 1991-04-23 Marion Laboratories, Inc. Stable liquid form of 5-aminosalicylic acid
WO2014016671A2 (en) * 2012-07-27 2014-01-30 Redhill Biopharma Ltd. Formulations and methods of manufacturing formulations for use in colonic evacuation
KR101420315B1 (ko) * 2014-03-19 2014-07-17 남봉길 약학적 액제 조성물
CN109310774A (zh) * 2015-08-17 2019-02-05 费林股份公司 含有匹可硫酸盐和柠檬酸镁的液体制剂

Also Published As

Publication number Publication date
US20220370427A1 (en) 2022-11-24
TW201804996A (zh) 2018-02-16
WO2018009761A1 (en) 2018-01-11
US20180015078A1 (en) 2018-01-18

Similar Documents

Publication Publication Date Title
AR108992A1 (es) Formulaciones líquidas estabilizadas que contienen picosulfato
CL2020000739A1 (es) Agente prolongado de control de ectoparasito para animales.
CL2019000586A1 (es) Composiciones de toxinas clostridiales no proteicas.
AR107776A2 (es) Composición de control del daño producido por insectos en plantas
AR098989A1 (es) Composiciones farmacéuticas que comprenden azd9291
UY34112A (es) Composiciones farmacéuticas que contienen un agente neuroléptico y un inhibidor sglt2 y usos de los mismos
GT201400106A (es) Composicion herbicida que contiene acido de 4-amino-3-cloro-6-(4-cloro-2-fluor-3-metoxifenil) piridina-2-carboxilico, o los derivados del mismo y fluroxipir, o los derivados del mismo
PE20130063A1 (es) Formulaciones orales y sales lipofilicas de metilnaltrexona
AR099886A1 (es) Dispersión sólida amorfa que comprende taxano, comprimido que comprende la misma, y método para su preparación
BR112016028697A2 (pt) artigos que fornecem fragrâncias de longa duração
BR112015027537A2 (pt) uso do ácido graxo de resina líquida
AR101581A1 (es) Composición de colutorio
AR102780A1 (es) Composiciones farmacéuticas, su preparación y sus usos
ECSP14026432A (es) (r)-nifuratel y síntesis de (r) y (s)-nifuratel
CL2017000230A1 (es) Composición adhesiva
UY38210A (es) Composiciones que contienen glufosinato y un herbicida de auxina sintética
AR094572A1 (es) Composiciones herbicidas que comprenden ácido 4-amino-3-cloro-6-(4-cloro-2-fluoro-3-metoxifenil)piridin-2-carboxílico o uno de sus derivados y picloram o uno de sus derivados
BR112018015095A2 (pt) recipiente de material de construção
CL2018003110A1 (es) Preparación y dispersión de formulaciones de emulsión estable.
UA116886C2 (uk) Препаративна форма йодосульфурон-метилу натрієвої солі
AR096704A1 (es) Formulación detergente higroscópica que comprende agua, agente quelante aminocarboxilato e ingredientes sensibles a la humedad
CO6210742A2 (es) Agentes que contienen n-fenilpirazol y carbonatos ciclicos alifaticos
CO2017001712A2 (es) Formulaciones de compuestos biológicos para instilación
CL2018002802A1 (es) Formulaciones pesticidas de compuestos orgánicos no volátiles. (divisional solicitud 201702142)
BR112016006153A2 (pt) composição contendo polietileno glicol

Legal Events

Date Code Title Description
FB Suspension of granting procedure